Literature DB >> 16441832

Survival to discharge among patients treated with continuous renal replacement therapy.

Ron Wald1, Rushi Deshpande, Chaim M Bell, Joanne M Bargman.   

Abstract

Continuous renal replacement therapy (CRRT) is widely used in critically ill patients with acute renal failure (ARF). The survival of patients who require CRRT and the factors predicting their outcomes are not well defined. We sought to identify clinical features to predict survival in patients treated with CRRT. We reviewed the charts of all patients who received CRRT at the Toronto General Hospital during the year 2002. Our cohort (n=85) represented 97% of patients treated with this modality in 3 critical care units. We identified demographic variables, underlying diagnoses, transplantation status, location (medical-surgical, coronary, or cardiovascular surgery intensive care units), CRRT duration, baseline estimated glomerular filtration rate (eGFR), and presence of oliguria (<400 mL/day) on the day of CRRT initiation. The principal outcome was survival to hospital discharge. Among those alive at discharge, we assessed whether there was an ongoing need for renal replacement therapy. Greater than one-third (38%, 32/85) of patients survived to hospital discharge. Three (9%) survivors remained dialysis-dependent at the time of discharge. Survivors were younger than nonsurvivors (mean age 56 vs. 60 years), were on CRRT for a shorter duration (7 vs. 13 days), and had a higher baseline eGFR (74 vs. 62 mL/min/m(2)). Patient survival varied among different critical care units (medical surgical 33%, coronary 38%, and cardiovascular surgery 45%). Multivariable logistic regression revealed that shorter duration of CRRT, nonoliguria, and baseline eGFR >60 mL/min/m(2) were independently associated with survival to hospital discharge (p<0.05). Critically ill patients with ARF who require CRRT continue to have high in-hospital mortality. A shorter period of CRRT dependence, nonoliguria and higher baseline renal function may predict a more favorable prognosis. The majority of CRRT patients who survive their critical illness are independent of dialysis at the time of hospital discharge.

Entities:  

Mesh:

Year:  2006        PMID: 16441832     DOI: 10.1111/j.1542-4758.2006.01179.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  11 in total

1.  Fluid overload and outcomes in neonates receiving continuous renal replacement therapy.

Authors:  Sang Taek Lee; Heeyeon Cho
Journal:  Pediatr Nephrol       Date:  2016-03-14       Impact factor: 3.714

2.  Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement Therapy.

Authors:  Mohammad H Al-Shaer; Kelly Maguigan; Jennifer Ashton; Veena Venugopalan; Molly E Droege; Carolyn D Philpott; Christopher A Droege; Daniel P Healy; Eric W Mueller; Charles A Peloquin
Journal:  Antimicrob Agents Chemother       Date:  2021-10-18       Impact factor: 5.938

3.  Comparison of Urine Output among Patients Treated with More Intensive Versus Less Intensive RRT: Results from the Acute Renal Failure Trial Network Study.

Authors:  Finnian R Mc Causland; Josephine Asafu-Adjei; Rebecca A Betensky; Paul M Palevsky; Sushrut S Waikar
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-22       Impact factor: 8.237

4.  Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy.

Authors:  Vin-Cent Wu; Wen-Je Ko; Hong-Wei Chang; Yung-Wei Chen; Yu-Feng Lin; Chih-Chung Shiao; Yung-Ming Chen; Yih-Sharng Chen; Pi-Ru Tsai; Fu-Chang Hu; Jann-Yuan Wang; Yen-Hung Lin; Kwan-Dun Wu
Journal:  Intensive Care Med       Date:  2007-08-15       Impact factor: 17.440

5.  Long-term sequelae of severe acute kidney injury in the critically ill patient without comorbidity: a retrospective cohort study.

Authors:  Gijs Fortrie; Susanne Stads; Albert-Jan H Aarnoudse; Robert Zietse; Michiel G Betjes
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  Delta neutrophil index is an independent predictor of mortality in septic acute kidney injury patients treated with continuous renal replacement therapy.

Authors:  In Mi Han; Chang-Yun Yoon; Dong Ho Shin; Youn Kyung Kee; Seung Gyu Han; Young Eun Kwon; Kyoung Sook Park; Mi Jung Lee; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Shin-Wook Kang; Tae-Hyun Yoo
Journal:  BMC Nephrol       Date:  2017-03-20       Impact factor: 2.388

7.  Biomarkers Predicting Survival of Sepsis Patients Treated with Continuous Renal Replacement Therapy.

Authors:  Jeong Ho Lee; Ha Yeon Kim; Eun Hui Bae; Soo Wan Kim; Seong Kwon Ma
Journal:  Chonnam Med J       Date:  2017-01-25

8.  Prolonged exposure to continuous renal replacement therapy in patients with acute kidney injury.

Authors:  Khaled Shawwa; Panagiotis Kompotiatis; Ankit Sakhuja; Paul McCarthy; Kianoush B Kashani
Journal:  J Nephrol       Date:  2021-06-23       Impact factor: 3.902

9.  Continuous renal replacement therapy for the treatment of acute kidney injury.

Authors:  Woo Kvun Bae; Dae Hun Lim; Ji Min Jeong; Hae Young Jung; Seong Ku Kim; Jeong Woo Park; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim; Nam Ho Kim; Ki Chul Choi
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 3.165

10.  Factors Associated with Early Mortality in Critically Ill Patients Following the Initiation of Continuous Renal Replacement Therapy.

Authors:  Youn Kyung Kee; Dahye Kim; Seung-Jung Kim; Duk-Hee Kang; Kyu Bok Choi; Hyung Jung Oh; Dong-Ryeol Ryu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.